A method used to design a microchip (DNA microarray) for identifying the
presence of prostate tumor, evaluating its degree of mali-gnity
(typization, characterization) and supplying information allowing
prediction of the clinical course of the illness (prognosis) is discussed
below. The method is based on assessment of the levels of expression of a
definite package of genes in the tumoral tissue in comparison with the
corresponding benign tissue. The readings thus obtained, - alone, in
different combinations with each other or in different combinations and
integrated with standardized clinical data - give the results described
above.